OKYO (OKYO) Stock Price & Analysis
OKYO (OKYO) fell 3.14% to USD 1.54 as of June 10, 2026 at 09:46 UTC, according to Nexqual real-time market data.
OKYO last closed at USD 1.59; the session ranged USD 1.54–1.63 on volume of 41,283 shares. Market capitalization is $80.82M, with a 52-week range of USD 1.44–3.35 (NCM). Source: Nexqual, June 10, 2026 at 09:46 UTC.
Key Statistics (as of June 10, 2026 at 09:46 UTC)
| Price | USD 1.54 |
|---|---|
| Change | ▼ 3.14% (down) |
| Previous Close | USD 1.59 |
| Open | USD 1.59 |
| Day Range | USD 1.54 – 1.63 |
| 52-Week Range | USD 1.44 – 3.35 |
| Volume | 41,283 shares |
| Market Cap | $80.82M |
| Exchange | NCM |
Technical Analysis (OKYO)
Nexqual's technical model rates OKYO "SELL" based on 1 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 09:46 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.27 (neutral) |
| vs SMA50 | Below (USD 1.62) |
| MACD | 0.01 (positive) |
Analyst Ratings (OKYO)
Wall Street analysts rate OKYO "None" based on 3 analysts, with a mean price target of USD 9 (range USD 7–13), per Nexqual as of June 10, 2026 at 09:46 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 9 |
| High Target | USD 13 |
| Low Target | USD 7 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (OKYO)
| Revenue Estimate | $0 |
|---|
Source: Nexqual, June 10, 2026 at 09:46 UTC.
Financials & Fundamentals (OKYO)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.58 |
| Total Cash | $4.22M |
| Total Debt | $185,795 |
| Free Cash Flow | $-3.00M |
Source: Nexqual, June 10, 2026 at 09:46 UTC.
Financial Health Score (OKYO)
Nexqual rates OKYO's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 09:46 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $4M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$3M |
| Efficiency | Mixed — No data |
Ownership (OKYO)
| Insider Ownership | +30.41% |
|---|---|
| Institutional Ownership | +20.81% |
| Shares Outstanding | 52.48M |
| Float | 20.77M |
| Short % of Float | +0.29% |
Source: Nexqual, June 10, 2026 at 09:46 UTC.
Leadership (OKYO)
OKYO is led by Robert J. Dempsey, CEO & Executive Director, per Nexqual as of June 10, 2026 at 09:46 UTC.
| CEO & Executive Director | Robert J. Dempsey |
|---|---|
| Chief Development Officer & Director | Gary S. Jacob (age 78) |
| Chief Financial Officer | Keeren Shah (age 49) |
| Chief Scientific Officer | Rajkumar Patil (age 66) |
Major Backers & Investors (OKYO)
Notable institutional backers of OKYO include Woodline Partners LP, Maven Securities Limited, Stonepine Capital Management, LLC, according to Nexqual as of June 10, 2026 at 09:46 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Woodline Partners LP | 9.01% |
| Maven Securities Limited | 2.9% |
| Stonepine Capital Management, LLC | 2.1% |
| Balyasny Asset Management LP | 1.44% |
| UBS Group AG | 0.15% |
Source: Nexqual, June 10, 2026 at 09:46 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MAIA | MAIA Biotechnology, Inc. | USD 1.3 | ▼ 4.41% |
| SXTP | 60 Degrees Pharmaceuticals, Inc | USD 1.39 | ▼ 2.11% |
| DRMA | Dermata Therapeutics, Inc. | USD 1.2 | ▲ 1.69% |
| SPRC | SciSparc Ltd. | USD 9.31 | ▼ 18.62% |
| SHPH | Shuttle Pharmaceuticals Holding | USD 0.45 | ▼ 0.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:46 UTC. This page is informational and not investment advice.